Table 1.
Investigation | V0 | V1 | V6 | V12 | V18 | V24 | V30 | V36 | V42* | V48* |
History | × | |||||||||
Clinical examination | × | × | × | × | × | × | ||||
QLMI questionnaire | A | B | B | B† | B | B† | B | B† | B | B† |
Blood pressure | × | × | × | × | × | × | × | × | × | |
ECG | × | × | × | × | × | × | ||||
Laboratory tests | × | × | × | × | × | × | ||||
Smoking + S-cotinine | × | × | × | × | × | × | × | × | × | × |
Exercise level | × | × | × | × | × | × | × | × | ||
Nutrition + BMI | × | × | × | × | × | × | × | × | × | |
Alcohol status | × | × | × | × | × | × | × | × | × | × |
ETT | ×†× | × | × | |||||||
Medication | × | × | × | × | × | × | × | × | × | × |
Adverse events | × | × | × | × | × | × | × | × | × | × |
*If applicable. †Patient's evaluation questionnaire. ‡ETT at the start and the end of 8 weeks of supervised exercise training.V0-V48, visits at 6-month intervals; BMI, basal metabolic index.